CCND1 |
CCND1, BCL1, PRAD1: G1/S-specific cyclin-D1 |
BRCA1 |
BRCA1, RNF53: Breast cancer type 1 susceptibility protein |
13.2 |
Evidence |
O
|
APOA1 |
APOA1: Apolipoprotein A-I precursor |
TTR |
TTR, PALB: Transthyretin precursor |
13.120 |
Evidence |
|
LCK |
LCK: Proto-oncogene tyrosine-protein kinase LCK |
DEF6 |
DEF6, IBP: Differentially expressed in FDCP 6 |
13.120 |
Evidence |
|
DAPP1 |
IPI00004301 |
LYN |
LYN: Tyrosine-protein kinase Lyn |
13.120 |
Evidence |
|
LAT |
LAT: Linker for activation of T-cells family member 1 |
ZAP70 |
ZAP70: Uncharacterized protein ZAP70 |
13.010 |
Evidence |
|
LAT |
LAT: Linker for activation of T-cells family member 1 |
LCK |
LCK: Proto-oncogene tyrosine-protein kinase LCK |
13.010 |
Evidence |
|
CCR5 |
CCR5: CCR5 receptor (Fragment) |
STAT3 |
|
13.010 |
Evidence |
|
GHR |
GHR: Growth hormone receptor precursor |
STAT3 |
|
13.010 |
Evidence |
|
IL2RB |
IL2RB: Interleukin-2 receptor subunit beta precursor |
STAT3 |
|
13.010 |
Evidence |
|
PSEN1 |
PSEN1, AD3, PS1, PSNL1: Presenilin-1 |
CASP6 |
CASP6, MCH2: Caspase-6 precursor |
13.010 |
Evidence |
|
JUN |
JUN: Transcription factor AP-1 |
MAPK8 |
MAPK8, JNK1, PRKM8: Mitogen-activated protein kinase 8 |
13.010 |
Evidence |
|
NBN |
NBN, NBS, NBS1, P95: Nibrin |
RAD50 |
RAD50: DNA repair protein RAD50 |
13.010 |
Evidence |
|
MAPK8 |
MAPK8, JNK1, PRKM8: Mitogen-activated protein kinase 8 |
HSF1 |
HSF1, HSTF1: Heat shock factor protein 1 |
13.010 |
Evidence |
|
PRKCG |
PRKCG, PKCG: Protein kinase C gamma type |
IRS1 |
IRS1: Insulin receptor substrate 1 |
12.980 |
Evidence |
|
ESR1 |
ESR1, ESR, NR3A1: Estrogen receptor |
CREBBP |
CREBBP, CBP: CREB-binding protein |
12.980 |
Evidence |
|
ARPC1B |
ARC41, ARPC1B: Actin-related protein 2/3 complex subunit 1B |
ACTG1 |
ACTB: Actin, cytoplasmic 1 |
12.840 |
Evidence |
|
TRADD |
TRADD: Tumor necrosis factor receptor type 1-associated DEATH domain protein |
FAS |
Tumor necrosis factor receptor superfamily, member 6 isoform 1 variant (Fragment |
12.800 |
Evidence |
|
RIPK1 |
RIPK1, RIP: Receptor-interacting serine/threonine-protein kinase 1 |
FAS |
Tumor necrosis factor receptor superfamily, member 6 isoform 1 variant (Fragment |
12.800 |
Evidence |
|
BAX |
BAX: Apoptosis regulator BAX, cytoplasmic isoform beta |
MCL1 |
MCL1: Induced myeloid leukemia cell differentiation protein Mcl-1 |
12.800 |
Evidence |
|
PDHA1 |
PDHA1, PHE1A: Pyruvate dehydrogenase E1 component subunit alpha, somatic form, m |
PDK4 |
PDK4: [Pyruvate dehydrogenase [lipoamide]] kinase isozyme 4, mitochondrial precu |
12.790 |
Evidence |
|
CBL |
CBL, CBL2, RNF55: E3 ubiquitin-protein ligase CBL |
KHDRBS1 |
KHDRBS1, SAM68: KH domain-containing, RNA-binding, signal transduction-associate |
12.710 |
Evidence |
|
RPLP2 |
RPLP2, D11S2243E, RPP2: 60S acidic ribosomal protein P2 |
RPLP0 |
RPLP0: 60S acidic ribosomal protein P0 |
12.690 |
Evidence |
O
|
JAK2 |
JAK2: Tyrosine-protein kinase JAK2 |
TNFRSF1A |
TNFRSF1A, TNFAR, TNFR1: Tumor necrosis factor receptor superfamily member 1A pre |
12.670 |
Evidence |
O
|
HGS |
HGS, HRS: Hepatocyte growth factor-regulated tyrosine kinase substrate |
STAM |
STAM, STAM1: Signal transducing adapter molecule 1 |
12.660 |
Evidence |
|
HDAC3 |
HDAC3: Histone deacetylase 3 |
NFKBIA |
NFKBIA, IKBA, MAD3, NFKBI: NF-kappa-B inhibitor alpha |
12.630 |
Evidence |
|